Additional measures novel coronavirus COVID-19 RIVM has advised the Dutch government that additional measures are needed throughout the Netherlands to prevent the spread of COVID-19.
Results of random sample test: 4% of hospital staff infected with coronavirus Nearly four per cent of the hospital staff examined in Brabant is infected with the novel coronavirus (COVID-19). A random sample test by RIVM between 6 and 9 March reveals this.
COVID-19: Advice for residents of Noord-Brabant RIVM advises residents of the province of Noord-Brabant to limit their social contacts if they have a cold, cough or a fever. This means: stay at home.
Patient with novel coronavirus deceased An 86-year-old man who was hospitalised in the Ikazia hospital Rotterdam with COVID-19 has died. The source of infection of the patient remains unknown.
Eight new patients, Maasstad Hospital closes ICU department To date, Monday 2 March, eight new patients have been reported to RIVM. This brings the total number of positive tests in the Netherlands to 18.
Three new patients with novel coronavirus (COVID-19) Three new patients were diagnosed with the novel coronavirus (COVID-19) on March 1st, bringing the number of coronavirus patients in the Netherlands to ten.
Patient with COVID-19 in Delft On 29 February, a woman in Delft was diagnosed with the novel coronavirus (COVID-19) in the Netherlands. The woman had been in Lombardy, in Northern Italy, last week.
Patient with novel coronavirus COVID-19 in the Netherlands A patient in the Netherlands was diagnosed with the novel coronavirus (COVID-19). Tests confirmed this today.
German coronavirus patient not sick during stay in Limburg On Tuesday evening 25 February, it was announced that a German man was tested positive for COVID-19. He would have been in the Netherlands last week.
Towards a sustainable, healthy future for everyone: EU project INHERIT offers policy solutions Today, on 10 December a policy toolkit will be presented at the final conference of the European four-year research project INHERIT.